FDA issues an Early Communication about an Ongoing Safety Review for Botox
This is a discussion on FDA issues an Early Communication about an Ongoing Safety Review for Botox within the FDA News forum, part of the Industry News and Updates category; FDA issues an Early Communication about an Ongoing Safety Review for Botox and Botox Cosmetic (Botulinum toxin Type A) and ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
02-26-2008, 03:30 PM
|
|||
|
|||
FDA issues an Early Communication about an Ongoing Safety Review for Botox
FDA issues an Early Communication about an Ongoing Safety Review for Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA Issues Early Communication about an Ongoing Review of Vytorin | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |